Export 691 results:
Author Keyword Title [ Type(Desc)] Year
Filters: Keyword is Humans  [Clear All Filters]
Journal Article
H. Zong Ying Wu, Ong, K. Leung, Seeher, K., Armstrong, N. J., Thalamuthu, A., Brodaty, H., Sachdev, P., and Mather, K., Circulating microRNAs as Biomarkers of Alzheimer's Disease: A Systematic Review., J Alzheimers Dis, vol. 49, no. 3, pp. 755-66, 2016.
D. A. Nation, Tan, A., Dutt, S., McIntosh, E. C., Yew, B., Ho, J. K., Blanken, A. E., Jang, J. Yun, Rodgers, K. E., and Gaubert, A., Circulating Progenitor Cells Correlate with Memory, Posterior Cortical Thickness, and Hippocampal Perfusion., J Alzheimers Dis, vol. 61, no. 1, pp. 91-101, 2018.
L. Wang, Qiao, Y., Zhang, H., Zhang, Y., Hua, J., Jin, S., and Liu, G., Circulating Vitamin D Levels and Alzheimer's Disease: A Mendelian Randomization Study in the IGAP and UK Biobank., J Alzheimers Dis, vol. 73, no. 2, pp. 609-618, 2020.
T. Nagata, Shinagawa, S., Nakajima, S., Plitman, E., Mihashi, Y., Hayashi, S., Mimura, M., and Nakayama, K., Classification of Neuropsychiatric Symptoms Requiring Antipsychotic Treatment in Patients with Alzheimer's Disease: Analysis of the CATIE-AD Study., J Alzheimers Dis, vol. 50, no. 3, pp. 839-45, 2016.
T. Särkämö, Laitinen, S., Numminen, A., Kurki, M., Johnson, J. K., and Rantanen, P., Clinical and Demographic Factors Associated with the Cognitive and Emotional Efficacy of Regular Musical Activities in Dementia., J Alzheimers Dis, vol. 49, no. 3, pp. 767-81, 2016.
D. Andriuta, Si-Ahmed, C., Roussel, M., Constans, J. - M., Makki, M., Aarabi, A., Basille, D., Andrejak, C., and Godefroy, O., Clinical and Imaging Determinants of Neurocognitive Disorders in Post-Acute COVID-19 Patients with Cognitive Complaints., J Alzheimers Dis, vol. 87, no. 3, pp. 1239-1250, 2022.
M. Chung, Rhee, H. Young, and Chung, W. Kuu, Clinical Approach of Low-Dose Whole-Brain Ionizing Radiation Treatment in Alzheimer's Disease Dementia Patients., J Alzheimers Dis, vol. 80, no. 3, pp. 941-947, 2021.
Y. - L. Chang, Yen, Y. - S., Chen, T. - F., Yan, S. - H., and Tseng, W. - Y. Isaac, Clinical Dementia Rating Scale Detects White Matter Changes in Older Adults at Risk for Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 2, pp. 411-23, 2016.
D. Bergeron, Beauregard, J. - M., Guimond, J., Fortin, M. - P., Houde, M., Poulin, S., Verret, L., Bouchard, R. W., and Laforce, R., Clinical Impact of a Second FDG-PET in Atypical/Unclear Dementia Syndromes., J Alzheimers Dis, vol. 49, no. 3, pp. 695-705, 2016.
J. Cummings, Ritter, A., and Zhong, K., Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future., J Alzheimers Dis, vol. 64, no. s1, pp. S3-S22, 2018.
Q. Lin Chan, Xu, X., Shaik, M. Amin, Chong, S. Shih Tsze, Hui, R. Jor Yeong, Chen, C. Li- Hsian, and Dong, Y. H., Clinical utility of the informant AD8 as a dementia case finding instrument in primary healthcare., J Alzheimers Dis, vol. 49, no. 1, pp. 121-7, 2016.
M. Grassi, Perna, G., Caldirola, D., Schruers, K., Duara, R., and Loewenstein, D. A., A Clinically-Translatable Machine Learning Algorithm for the Prediction of Alzheimer's Disease Conversion in Individuals with Mild and Premild Cognitive Impairment., J Alzheimers Dis, vol. 61, no. 4, pp. 1555-1573, 2018.
I. Álvarez, Aguilar, M., González, J. Manuel, Ysamat, M., Lorenzo-Bosquet, C., Alonso, A., Tartari, J. Pablo, Romero, S., Diez-Fairen, M., Carcel, M., Pujalte, F., and Pastor, P., Clinic-Based Validation of Cerebrospinal Fluid Biomarkers with Florbetapir PET for Diagnosis of Dementia., J Alzheimers Dis, vol. 61, no. 1, pp. 135-143, 2018.
R. Thangavel, Bhagavan, S. M., Ramaswamy, S. Beladakere, Surpur, S., Govindarajan, R., Kempuraj, D., Zaheer, S., Raikwar, S., Ahmed, M. E., Selvakumar, G. Pushpavath, Iyer, S. S., and Zaheer, A., Co-Expression of Glia Maturation Factor and Apolipoprotein E4 in Alzheimer's Disease Brain., J Alzheimers Dis, vol. 61, no. 2, pp. 553-560, 2018.
S. G. Ryman, Yutsis, M., Tian, L., Henderson, V. W., Montine, T. J., Salmon, D. P., Galasko, D., and Poston, K. L., Cognition at Each Stage of Lewy Body Disease with Co-occurring Alzheimer's Disease Pathology., J Alzheimers Dis, vol. 80, no. 3, pp. 1243-1256, 2021.
C. Rattanabannakit, Risacher, S. L., Gao, S., Lane, K. A., Brown, S. A., McDonald, B. C., Unverzagt, F. W., Apostolova, L. G., Saykin, A. J., and Farlow, M. R., The Cognitive Change Index as a Measure of Self and Informant Perception of Cognitive Decline: Relation to Neuropsychological Tests., J Alzheimers Dis, vol. 51, no. 4, pp. 1145-55, 2016.
C. Costa, Vecchio, F., Romoli, M., Miraglia, F., Cesarini, E. Nardi, Alù, F., Calabresi, P., and Rossini, P. Maria, Cognitive Decline Risk Stratification in People with Late-Onset Epilepsy of Unknown Etiology: An Electroencephalographic Connectivity and Graph Theory Pilot Study., J Alzheimers Dis, vol. 88, no. 3, pp. 893-901, 2022.
J. Cummings, Schwartz, G. G., Nicholls, S. J., Khan, A., Halliday, C., Toth, P. P., Sweeney, M., Johansson, J. O., Wong, N. C. W., Kulikowski, E., Kalantar-Zadeh, K., Lebioda, K., Ginsberg, H. N., Winblad, B., Zetterberg, H., and Ray, K. K., Cognitive Effects of the BET Protein Inhibitor Apabetalone: A Prespecified Montreal Cognitive Assessment Analysis Nested in the BETonMACE Randomized Controlled Trial., J Alzheimers Dis, vol. 83, no. 4, pp. 1703-1715, 2021.
S. Jeong, Huang, L. - K., Tsai, M. - J., Liao, Y. - T., Lin, Y. - S., Hu, C. - J., and Hsu, Y. - H., Cognitive Function Associated with Gut Microbial Abundance in Sucrose and S-Adenosyl-L-Methionine (SAMe) Metabolic Pathways., J Alzheimers Dis, vol. 87, no. 3, pp. 1115-1130, 2022.
A. Tsiakiri, Vlotinou, P., Terzoudi, A., Heliopoulos, I., and Vadikolias, K., Cognitive, Functional, and Emotional Changes During the COVID-19 Pandemic in Greek Patients with Neurocognitive Disorders., J Alzheimers Dis, vol. 88, no. 2, pp. 537-547, 2022.
N. Kandiah, Chander, R. Jude, Lin, X., Ng, A., Poh, Y. Yeong, Cheong, C. Yee, Cenina, A. Rae, and Assam, P. Nkouibert, Cognitive Impairment after Mild Stroke: Development and Validation of the SIGNAL2 Risk Score., J Alzheimers Dis, vol. 49, no. 4, pp. 1169-77, 2016.
P. Martín-Jiménez, Muñoz-García, M. I., Seoane, D., Roca-Rodríguez, L., García-Reyne, A., Lalueza, A., Maestro, G., Folgueira, D., Blanco-Palmero, V. A., San Martín, A. Herrero-, Llamas-Velasco, S., Pérez-Martínez, D. A., González-Sánchez, M., and Villarejo-Galende, A., Cognitive Impairment Is a Common Comorbidity in Deceased COVID-19 Patients: A Hospital-Based Retrospective Cohort Study., J Alzheimers Dis, vol. 78, no. 4, pp. 1367-1372, 2020.
L. Xiong, Davidsdottir, S., Reijmer, Y. D., Shoamanesh, A., Roongpiboonsopit, D., Thanprasertsuk, S., Martinez-Ramirez, S., Charidimou, A., Ayres, A. M., Fotiadis, P., Gurol, E., Blacker, D. L., Greenberg, S. M., and Viswanathan, A., Cognitive Profile and its Association with Neuroimaging Markers of Non-Demented Cerebral Amyloid Angiopathy Patients in a Stroke Unit., J Alzheimers Dis, vol. 52, no. 1, pp. 171-8, 2016.
Y. Stern, Cognitive reserve in ageing and Alzheimer's disease., Lancet Neurol, vol. 11, no. 11, pp. 1006-12, 2012.
M. Balietti, Giuli, C., Fattoretti, P., Fabbietti, P., Postacchini, D., and Conti, F., Cognitive Stimulation Modulates Platelet Total Phospholipases A2 Activity in Subjects with Mild Cognitive Impairment., J Alzheimers Dis, vol. 50, no. 4, pp. 957-62, 2016.